Figure 1.
Shock and kill approach aiming to reactivate latently infected cells by HDAC inhibition including suberoylanilide hydroxamic acid (SAHA), the BET bromodomain protein inhibitor (BET151), and anti-CTLA4 antibody and induce subsequent cell death due to viral toxicity and/or host immune defense while HIV-1 replication is inhibited by ART.